1. What is a Bar Date?

The Bar Date is the court approved deadline for filing claims against Purdue Pharma L.P., a U.S. limited partnership, its general partner, and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”), for money owed or harm you believe was caused by acts or omissions of any of the Debtors from before the September 15, 2019 Chapter 11 filing date. The Bar Date has been extended to July 30, 2020, at 5:00 p.m. Prevailing Eastern Time.

Proof of Claim forms and related documentation must be actually received by Purdue’s claims and noticing agent, Prime Clerk LLC, or the Bankruptcy Court on or before the Bar Date. A holder of a claim that arose prior to September 15, 2019 who fails to file a Proof of Claim on or before the Bar Date (unless exempted from the requirements of the Bar Date Order) will be forever barred, estopped, and enjoined from asserting that claim against the applicable Debtors, their property or their estates and will not be entitled to vote on any plan filed in the Debtors’ bankruptcy cases or to receive any distributions on account of that claim.

2. Why did I receive this legal notice?

The Bar Date Notice was provided to inform you of the Bar Date, which has been extended to July 30, 2020, at 5:00 p.m. Prevailing Eastern Time.

The Bar Date Notice was provided to all creditors and parties that are known to Purdue and that Purdue believes may have claims against any of the Debtors (Purdue Pharma L.P., a U.S. limited partnership, its general partner, and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”)). For example, the Bar Date Notice was sent to all employees, vendors, suppliers, and other contract counterparties of Purdue, current parties to litigation with Purdue, Purdue Opioid users who are included in an adverse event report or who filed a product complaint and provided contact information, callers to Purdue who have threatened, but not filed, litigation and provided contact information, entities and individuals that have requested indemnification, and prescribers of Purdue brand name prescription medications. The fact that you have received this notice does not mean that you have a claim or that Purdue or the Bankruptcy Court believe that you have a claim against Purdue.

The objective of the notice procedures is to successfully reach and inform known and unknown potential claimants of the deadline and process for filing proofs of claim in these chapter 11 cases. All known potential claimants will receive a copy of the Bar Date Notice. In addition, a supplemental notice program using various forms of media targeted to unknown potential claimants is being implemented in the United States and its territories and in Canada. The comprehensive Supplemental Notice Plan comprises an extensive advertising campaign utilizing network broadcast and cable television, terrestrial and streaming radio, newspaper, magazine, advanced television, out-of-home advertising, online video, online display, and social media.

3. Why didn’t I receive this legal notice?

You may or may not receive a copy of the Bar Date Notice, however, receipt or non-receipt of the Bar Date Notice does not determine whether you have a claim against the Debtors (Purdue Pharma L.P., a U.S. limited partnership, its general partner, or its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”)). If you did not receive a notice, it does not mean that you do or you do not have a claim against the Debtors. It just means that the Debtors were unaware of a claim you may have against the Debtors as of September 15, 2019. You can download the applicable Proof of Claim Form(s) from the Purdue case website here.

The objective of the notice procedures is to successfully reach and inform known and unknown potential claimants of the deadline and process for filing proofs of claim in these chapter 11 cases. All known potential claimants will receive a copy of the Bar Date Notice. In addition, a supplemental notice program using various forms of media targeted to unknown potential claimants is being implemented in the United States and its territories and in Canada. The comprehensive Supplemental Notice Plan comprises an extensive advertising campaign utilizing network broadcast and cable television, terrestrial and streaming radio, newspaper, magazine, advanced television, out-of-home advertising, online video, online display, and social media.

4. What is a “Claim"?

Under the Bankruptcy Code, a “claim” is defined as a right to a payment, including rights that are liquidated or unliquidated, contingent or fixed, matured or unmatured, disputed or undisputed, secured or unsecured.

A “claim” may also be a right to an equitable remedy for breach of performance by any of the Debtors (Purdue Pharma L.P., a U.S. limited partnership, its general partner, and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”)), if such breach gives rise to a right of payment.

A personal injury claim can include a claim for economic damages (lost wages, for example), pain and suffering, wrongful death, etc. A claim for a minor can include, for example, a claim for Neonatal Abstinence Syndrome (sometimes referred to as “NAS”) or other health issues related to prescription opioids.

5. Do I have a claim? What is my claim?

If you believe you were owed money by any of the Debtors (Purdue Pharma L.P., a U.S. limited partnership, its general partner, and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”)) before the September 15, 2019 Chapter 11 filing date, you may have a claim.

If you believe that you or another person (if, for example, you are filing a claim on behalf of a deceased or incapacitated individual or a minor) have been injured by Purdue or prescription opioids produced, marketed or sold by Purdue or its subsidiaries before the September 15, 2019 Chapter 11 filing date, you may have a claim.

If you are a claimant’s guardian, or other authorized caretaker, executor or authorized agent, you may file a Proof of Claim on behalf of the individual or estate that you represent.

If you do not believe you (or any estate you represent or any minor that you are the parent or guardian for) have a claim against Purdue, you do not need to do anything in response to any notice you may have received nor do you need to file a Proof of Claim form.

Purdue Pharma (Canada), Purdue Frederick Inc. (Canada) and Purdue Pharma Inc. (Canada) (collectively, “Purdue Canada”) are not Debtors and are not subject to this bankruptcy proceeding. If you have a claim only against Purdue Canada, you are not required to file or submit a Proof of Claim Form in this bankruptcy proceeding. Certain claims against Purdue Canada remain subject to an existing Canadian settlement approval process.

Neither Prime Clerk nor Purdue can provide advice as to whether you may have a claim. You should review your own records to determine if you are owed money by Purdue from before the September 15, 2019 Chapter 11 filing date or if you believe that you have been injured by Purdue products produced, marketed or sold by Purdue before the September 15, 2019 Chapter 11 filing date.

Additionally, you can review the Schedules of Assets and Liabilities (“schedules”) which were filed by each Debtor and reflect the amounts each Debtor believes they may owe creditors as of the time of the Chapter 11 filing. A copy of the filed schedules is available for review on the court docket. You may access the court docket by visiting the Purdue case website here.

If you disagree with the amount, classification or scheduled Debtor, OR the amount is listed as Contingent, Unliquidated, or Disputed, you must file a Proof of Claim for any amount you are owed by Purdue from before the September 15, 2019 Chapter 11 filing date to preserve your rights to distributions on account of such claim under any plan of reorganization.

If you agree with the scheduled amount, classification and asserted Debtor, and the amount is not listed as Contingent, Unliquidated or Disputed, you are not required to file a Proof of Claim form.

If you require further assistance, you may wish to contact your own personal legal counsel.

If you believe that you may have a claim, you can find instructions on how to file a Proof of Claim here.

6. What is a Proof of Claim?

A “Proof of Claim” is the official form that a creditor or other interested party (or litigant, or someone who believes that Purdue has caused them damages) must submit in order to assert and support any claim against any or all of the Debtors (Purdue Pharma L.P., a U.S. limited partnership, its general partner, and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”)).

The Bankruptcy Court has approved four Proof of Claim Forms that seek certain baseline information that will be important for evaluating claims filed against the Debtors. These forms are: (i) a Non-Opioid Claimant Proof of Claim Form; (ii) a Governmental Opioid Claimant Proof of Claim Form; (iii) a General Opioid Claimant Proof of Claim Form; and (iv) a Personal Injury Claimant Proof of Claim Form.

You can download the applicable Proof of Claim Form(s) from Purdue’s restructuring website here.

Each Proof of Claim Form contains instructions that describe the types of claimants that should use such form and the types of claims that should be asserted using such form. Additional information regarding each Proof of Claim Form is also provided below in question 7.

All Personal Injury Claimant Proof of Claim Forms and any supporting documentation submitted with those forms will remain highly confidential and will not be made available to the public.

Each Proof of Claim Form must be signed by the creditor, or by an authorized agent of the creditor if the creditor is not an individual. If you are an individual submitting a Proof of Claim Form on behalf of yourself (or filing a claim on behalf of a decedent’s estate, or filing a claim as parent or guardian on behalf of a minor), you are considered a creditor for the purposes of the Proof of Claim process, and you or your authorized agent must sign your Proof of Claim.

You may attach to each Proof of Claim Form copies of any documents on which the claim is based (if voluminous, a summary may be attached), but you are not required to do so, and failure to attach any such documents will not affect your ability to submit a proof of claim. Please do not send original documents with your Proof of Claim, as they will not be returned to you and may be destroyed after they are processed and reviewed.

7. Which form should I use?

There are four distinct proof of claim forms.

Personal Injury Claimant Proof of Claim Form:

  • If you are asserting a claim against the Debtors (Purdue Pharma L.P., a U.S. limited partnership, its general partner, and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”)) based on your own personal injury or another person’s personal injury (for example, you are filing on behalf of a deceased or incapacitated individual or a minor) related to the taking of a Purdue Opioid and/or the taking of another opioid for which you believe Purdue is responsible for your damages, you must file the Personal Injury Claimant Proof of Claim Form.
  • For example, individuals seeking damages for death, addiction or dependence, lost wages, loss of consortium, or Neonatal Abstinence Syndrome (sometimes referred to as “NAS”), regardless of the legal cause of action (fraud, negligence, misrepresentation, conspiracy, etc.), must file the Personal Injury Claimant Proof of Claim Form.
  • If you are asserting a claim against the Debtors based on the Debtors’ production, marketing and sale of Purdue Opioids, in addition to your claim based on personal injury as a result of taking a Purdue Opioid or another opioid, you may include those claims on the Personal Injury Claimant Proof of Claim Form by completing Part 5 of the Personal Injury Claimant Proof of Claim Form.

Confidentiality: All Personal Injury Claimant Proof of Claim Forms and any supporting documentation submitted with those forms will remain highly confidential and will not be made available to the public. Only the claim number, claim amount, and the total number and amount of the personal injury claims, including any subcategories thereof (such as claims on behalf of minors with Neonatal Abstinence Syndrome, sometimes referred to as “NAS”) will be made publicly available on the case website and only such information will be included in the publicly available Claims Register.

Copies of Personal Injury Claimant Proof of Claim Forms and supporting documentation shall, as applicable, be treated as information protected pursuant to the Health Insurance Portability and Accountability Act of 1996 as set forth in the Protective Order to be submitted for entry by the Court, and made available only to Prime Clerk, the Court and those that agree to be bound by the Protective Order entered at Docket No. 784.

Governmental Opioid Claimant Proof of Claim Form:

  • If you are a governmental unit or a Native American Tribe, and you are asserting a claim against the Debtors based on or involving opioids or their production, marketing and sale, including without limitation, the Debtors’ production, marketing and sale of Purdue Opioids, you must file the Governmental Opioid Claimant Proof of Claim Form.

General Opioid Claimant Proof of Claim Form:

  • If you are a person or entity, other than a governmental unit or Native American Tribe, and you are asserting a claim against the Debtors based on or involving opioids or their production, marketing and sale, including without limitation, the Debtors’ production, marketing and sale of Purdue Opioids, excluding claims for personal injury, you must file the General Opioid Claimant Proof of Claim Form.
  • For example, hospitals, insurers, third-party payors, or insureds seeking damages for an injury other than a personal injury—a financial or economic injury, for instance—must file the General Opioid Claimant Proof of Claim Form.
  • If you are asserting a claim against the Debtors based on non-opioid-related injuries or harm, in addition to your claim based on the Debtors’ production, marketing and sale of Purdue Opioids, you may include those claims on the General Opioid Claimant Proof of Claim Form by filling out Part 4 on the General Opioid Claimant Proof of Claim Form.

Non-Opioid Claimant Proof of Claim Form (Official Form 410):

  • If you are a person or entity and you are asserting a claim against the Debtors based on non-opioid related injuries or harm, you must file the Non-Opioid Claimant Proof of Claim Form (Official Form 410).
  • For example, trade creditors seeking outstanding payments or governmental units asserting tax claims must file the Non-Opioid Claimant Proof of Claim Form.
  • Any holder of a claim against more than one Debtor for non-opioid related injuries or harm must file a separate proof of claim with respect to each such Debtor, and all holders of such claims must identify on their proof of claim the specific Debtor against which their claim is asserted and the case number of that Debtor’s bankruptcy case.
  • A list of the names of the Debtors and their case numbers is set forth in the table on the first page of this Notice.

8. What is a Purdue Opioid?

Purdue Opioid means all natural, semi-synthetic or synthetic chemicals that interact with opioid receptors on nerve cells in the body and brain, and that are approved by the U.S. Food & Drug Administration (FDA) and listed by the DEA as Schedule II or III drugs pursuant to the federal Controlled Substances Act, produced, marketed or sold by the Debtors (Purdue Pharma L.P., a U.S. limited partnership, its general partner, or its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”)) as (i) the following Brand Name Medications: OxyContin®, Hysingla ER®, Butrans®, Dilaudid®, Ryzolt, MS Contin®, MSIR®, Palladone®, DHC Plus®, OxyIR®, and OxyFast®, and (ii) the following Generic Medications: oxycodone extended-release tablets, buprenorphine transdermal system, hydromorphone immediate-release tablets, hydromorphone oral solution, tramadol extended-release tablets, morphine extended-release tablets, oxycodone immediate-release tablets, oxycodone and acetaminophen tablets (generic to Percocet®), hydrocodone and acetaminophen tablets (generic to Vicodin® or Norco®).

The term “Purdue Opioid(s)” does not mean: (i) medications and other substances to treat opioid or other substance use disorders, abuse, addiction or overdose; (ii) raw materials and/or immediate precursors used in the manufacture or study of opioids or opioid products, but only when such materials and/or immediate precursors are sold or marketed exclusively to DEA-licensed manufacturers or DEA-licensed researchers; or (iii) opioids listed by the DEA as Schedule IV drugs pursuant to the federal Controlled Substances Act.

9. How do I know if I took a Purdue prescription medication?

The instructions to the Proof of Claim Forms contain a list of brand name and generic prescription medications produced, marketed or sold by Purdue Pharma L.P., a U.S. limited partnership, its general partner, or its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”).

You should review your own records to determine if you believe that you have been injured by Purdue or Purdue products produced, marketed or sold by Purdue before the September 15, 2019 Chapter 11 filing date.

10. Who is Prime Clerk?

Prime Clerk LLC has been appointed by the Bankruptcy Court to act as the official Claims and Noticing Agent for these cases, which role includes sending the Bar Date Notice and processing all Proof of Claim Forms.

Prime Clerk is not permitted to provide legal or financial advice. Prime Clerk’s role as claims and noticing agent is to receive, process, record claims as filed, and maintain the official claims register. Prime Clerk does not determine the validity or allowance of claims and is not able to determine whether or not a party should file a claim.

11. Do I need to file a Proof of Claim?

If you believe that you may have a claim that arose before the filing date of September 15, 2019 that has not been paid, you should consider whether to file a Proof of Claim.

If you (or, in the case of a (a) wrongful-death claim, the estate you represent or (b) claim on behalf of a minor or a baby, the minor or baby that you are the parent or guardian for) believe that you (or the person who has died or the minor) have been injured by Purdue Pharma L.P., a U.S. limited partnership, its general partner, or its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”) or Purdue prescription opioids produced, marketed or sold by the company or its subsidiaries before the September 15, 2019 Chapter 11 filing date, you should consider whether to file a Proof of Claim.

If you do not believe you (or any estate you represent or any minor that you are the parent or guardian for) have a claim against Purdue, you do not need to do anything in response to any notice you may have received nor do you need to file a Proof of Claim Form.

Purdue Pharma (Canada), Purdue Frederick Inc. (Canada) and Purdue Pharma Inc. (Canada) (collectively, “Purdue Canada”) are not Debtors and are not subject to this bankruptcy proceeding. If you have a claim only against Purdue Canada, you are not required to file or submit a Proof of Claim Form in this bankruptcy proceeding. Certain claims against Purdue Canada remain subject to an existing Canadian settlement approval process.

Other than claims asserted on any of the Opioid Proof of Claim Forms and claims asserted by the U.S. federal government, a separate proof of claim form must be filed for amounts owed by each Debtor.

In accordance with the Bar Date Order, certain individuals or entities do not need to file a Proof of Claim. Those exemptions are listed in the Bar Date Order.

12. How do I submit a claim?

Proofs of Claim will be deemed filed only when received by Prime Clerk by U.S. mail or hand delivery, or filed electronically through Prime Clerk’s website or the Court’s website, or received by the United States Bankruptcy Court for the Southern District of New York by hand delivery. You can find instructions on how to file a Proof of Claim on our website for these cases located here.

Proofs of claim delivered by hand to the Clerk’s Office of the Court that contain confidential information must be delivered in an envelope marked “CONFIDENTIAL.”

Submission of Proof of Claim Forms via email and/or facsimile transmission is not permitted.

13. Can I submit a proof of claim after the Bar Date?

A holder of a claim that arises prior to September 15, 2019 who fails to file a Proof of Claim on or before the Bar Date (unless exempted from the requirements of the Bar Date Order) will be forever barred, estopped, and enjoined from asserting that claim against the Debtors (Purdue Pharma L.P., a U.S. limited partnership, its general partner, or its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”)), their property or their estates and will not be entitled to vote on any plan filed in the Debtors’ bankruptcy cases or to receive any distributions on account of that claim.

14. Can I amend a claim after the Bar Date?

The general Bar Date in the bankruptcy case has been extended to July 30, 2020, at 5:00 p.m. Prevailing Eastern Time.

If you wish to adjust a Proof of Claim that was previously filed, you must fill out a new Proof of Claim Form and select the applicable box to indicate that it amends a previously filed claim, the applicable claim number that is being amended (if known) and the original submission date (if known). If your previous claim has not yet been assigned a claim number, please include the original submission date.

Prime Clerk will process into the claims register all claim amendments received after the Bar Date, but it is ultimately up to the Bankruptcy Court to determine how any claim amendments received after the Bar Date will be treated.

Timely filed Proofs of Claim may be amended after the Bar Date. However, a Proof of Claim cannot be amended to assert a new claim after the Bar Date.

15. How will I know that my claim was processed?

All Proof of Claim Forms submitted to Prime Clerk will be processed. Once a claim is processed, a claim acknowledgement letter will be mailed to the address listed on the Proof of Claim Form and the claim (unless it is a claim filed on the Personal Injury Claimant Proof of Claim Form, which will remain highly confidential and will not be made available to the public) will appear on the electronic claims register provided on the case website here. Regardless of the date the Proof of Claim is processed, your claim will be reflected with the actual date of receipt by Prime Clerk or the Bankruptcy Court. Claimants are also encouraged to contact Prime Clerk’s call center via phone ((844) 217-0912) or live chat to request confirmation of submitted claims.

Neither the processing of a Proof of Claim by Prime Clerk nor the appearance of a claim on the claims register is an admission or determination by any party as to the validity or allowance of such claim.

16. When will I be paid?

The Debtors (Purdue Pharma L.P., a U.S. limited partnership, its general partner, and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”)) and any other party in interest have the right to object to any filed Proof of Claim. If an objection is filed, you will be notified and a court date will be scheduled for the Bankruptcy Court to determine the appropriate amount, if any, of your allowed claim. If such a court date is scheduled, you are entitled to present additional materials in support of your proof of claim either before or at that hearing. You may also choose to have a lawyer represent you at any such hearing. If it is determined that you hold an allowed general unsecured claim against Purdue that is entitled to a distribution, you may receive a distribution in the amount of all or a portion of your claim at the end of Purdue’s bankruptcy cases, which, unless the claim is subject to a statutory priority or subordination, will generally be paid on the same priority level as all other general unsecured claims.

At this time, Purdue does not have a timeframe for when claims that are allowed by the Bankruptcy Court will be paid. Before any distributions are made, a plan of reorganization and disclosure statement will be filed with the Bankruptcy Court that will explain the claim distribution process and the amounts that will be paid on account of allowed claims. It can be several months or more after those documents are filed before any distributions are made.

17. What is a plan of reorganization?

A plan of reorganization is a document that explains how a Debtor proposes to pay the amounts it owes to its creditors. Once filed, this plan will be available for creditors to review. Who is entitled to vote on the plan will be determined at a later date. The amount you may receive under the plan also will be determined at a later date.

18. I did not receive a Bar Date Notice or Proof of Claim form. How can I obtain one?

If you would like to obtain a copy of the Bar Date Notice for informational purposes or need a Proof of Claim Form, you can find them on the case website here.

19. If I have further questions, who can I call?

If you have further questions about filing a claim, please call Prime Clerk, who is the Court-appointed Claims Agent in these cases. Prime Clerk can be reached at (844) 217-0912 (U.S./Canada) or (347) 859-8093 (International) or purduepharmainfo@primeclerk.com.

20. Does someone represent me in this matter/case? Is there a lawyer I can speak to?

The Official Committee of Unsecured Creditors (the “Committee”) was appointed in these cases to represent the interests of all unsecured creditors, including you if you have a claim.

The Committee can be reached via Kurtzman Carson Consultants (“KCC”), the Information Agent for the Committee, at (888) 647-1738 (U.S./Canada) or (310) 751-2625 (International) or https://www.kccllc.net/purduecreditors/inquiry.

You may also contact counsel to the Committee, Akin Gump Strauss Hauer & Feld LLP, as follows: purduecreditorinfo@akingump.com

21. Who do I call if I have a question about a Purdue product or would like to report an adverse event or reaction or product complaint with a Purdue product?

If your call is about filing a claim, or if you have questions regarding the status of your claim, or the chapter 11 bankruptcy restructuring process, please call 844-217-0912 (Toll-free) or +1 347-859-8093 or go to www.purduepharmaclaims.com. If, separate from the bankruptcy restructuring process, you have a medical concern about a Purdue product or wish to report an adverse event or reaction or product complaint with a product marketed or sold by Purdue Pharma L.P., a U.S. limited partnership, its general partner or its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio Health L.P., Rhodes Technologies, and Rhodes Pharmaceuticals L.P. (collectively, “Purdue” or the “Debtors”), please contact Purdue directly at (888) 726-7535, and follow the prompts.